GSK3B and pancreatic neoplasm: Notably, pancreatic cancer cell lines characteristically have increased GSK-3β Y216- and decreased S9-phosphorylation, suggesting that GSK-3β is largely in an activated state in PDAC to drive various pro-tumorigenic processes [20,21,22].